The biopsy devices market plays a crucial role in cancer diagnosis, helping healthcare professionals detect malignant cells and determine disease progression. With the growing global incidence of cancer and increasing demand for early, accurate diagnostics, the market has witnessed substantial expansion.

In 2024, the biopsy devices market was valued at USD 7.27 billion, and it is projected to reach USD 15.12 billion by 2034, growing at a CAGR of 7.6% during 2025–2034. This growth is fueled by technological advancements, expanding applications in oncology and non-oncology diagnostics, and the integration of imaging technologies for precision biopsy procedures.

Biopsy Devices Market Overview

A biopsy is a minimally invasive medical procedure used to extract tissue samples for examination. The biopsy devices market encompasses a wide range of tools, including needle-based instruments, liquid biopsy devices, localization wires, and biopsy tables. These tools are used in hospitals, diagnostic centers, cancer care facilities, and research institutions to diagnose cancers and other chronic diseases.

As personalized medicine and precision oncology gain traction, biopsy technologies are evolving to support faster, more accurate, and safer tissue sampling. The market is also witnessing a shift toward liquid biopsy, a non-invasive diagnostic method using blood samples to detect tumor biomarkers—offering promising alternatives to traditional tissue biopsy methods.

Biopsy Devices Market Size and Share

The global biopsy devices market size stood at USD 7.27 billion in 2024 and is expected to reach USD 15.12 billion by 2034, expanding at a CAGR of 7.6%.

  • North America dominates the market, driven by high cancer prevalence, well-established healthcare infrastructure, and widespread adoption of advanced diagnostic tools.

  • Europe follows closely, supported by government initiatives in early cancer detection and screening programs.

  • The Asia Pacific region is poised for the fastest growth, owing to increasing healthcare expenditure, awareness of preventive care, and rising cases of lung, breast, and prostate cancers.

The biopsy devices market is further segmented based on product type, guidance technique, application, end user, and region, offering valuable insights into growth opportunities across healthcare domains.

Request sample report: https://www.expertmarketresearch.com/reports/biopsy-devices-market/requestsample

Market Dynamics and Trends

Growing Cancer Prevalence

The global surge in cancer incidence is the primary growth driver for the biopsy devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, with more than 19 million new cases reported annually.

Technological Advancements in Biopsy Equipment

Manufacturers are investing heavily in robot-assisted biopsy systems, imaging-guided technologies (like MRI and ultrasound), and minimally invasive procedures. These advancements are enhancing accuracy, reducing patient discomfort, and improving sample quality.

Shift Toward Liquid Biopsy

The introduction of liquid biopsy instruments has revolutionized cancer diagnostics by enabling non-invasive, repeatable, and faster testing through circulating tumor DNA (ctDNA) and exosomes. This segment is expected to show exponential growth during the forecast period.

Rising Demand for Image-Guided Biopsy

Image-guided biopsy techniques—such as ultrasound, CT, and MRI-guided systems—allow precise tissue localization, increasing diagnostic accuracy and reducing complications.

Market Segmentation

By Product Type

  • Needle-Based Biopsy Instruments: Account for the largest market share due to their wide application in breast, lung, and kidney cancer diagnosis.

  • Liquid Biopsy Instruments: Expected to register the fastest growth, driven by their non-invasive nature and rapid results.

  • Biopsy Table and Localization Wire: Essential for guided procedures, especially in radiology-assisted diagnostics.

  • Procedure Tray and Others: Supportive components for biopsy operations and sample handling.

By Guidance Technique

  • Image-Guided Biopsy: Includes ultrasound, MRI, and CT-guided procedures for enhanced precision.

  • Non-Image Guided Biopsy: Used in standard tissue extraction without imaging assistance.

By Application

  • Breast Cancer: Dominates the segment due to increasing screening programs and high disease prevalence.

  • Lung and Prostate Cancer: Show robust demand for advanced biopsy tools, supported by growing male cancer cases.

  • Kidney and Bone Marrow Biopsy: Witnessing steady adoption for chronic disease and transplant assessments.

By End User

  • Hospitals and Clinics: The largest users of biopsy devices due to integrated diagnostic and surgical capabilities.

  • Diagnostic Centers and Cancer Centers: Key growth areas driven by the rise in outpatient diagnostic services.

  • Academic and Research Institutes: Increasing use in clinical research, biomarker analysis, and oncology studies.

By Region

  • North America – Largest market, supported by technological advancements and government cancer-screening initiatives.

  • Europe – Strong presence of medical device manufacturers and adoption of high-end diagnostic tools.

  • Asia Pacific – Fastest-growing region, driven by healthcare infrastructure development and increasing cancer awareness.

  • Latin America & Middle East and Africa – Emerging markets with improving healthcare access and diagnostic facilities.

Recent Developments in the Biopsy Devices Market

  • June 2024: Becton, Dickinson and Company launched an advanced vacuum-assisted biopsy system with improved tissue retrieval accuracy.

  • March 2024: Hologic Inc. expanded its breast biopsy portfolio by acquiring a leading oncology imaging firm.

  • 2023: Boston Scientific introduced a robotic-assisted biopsy device designed to minimize patient discomfort.

  • FUJIFILM Holdings Corporation developed AI-powered biopsy guidance software for precision tissue targeting.

These innovations are shaping a new era of diagnostics, emphasizing speed, safety, and reliability in biopsy procedures.

Market Opportunities and Challenges

Opportunities

  • Rising awareness of early cancer detection programs across emerging economies.

  • Integration of AI and robotics in biopsy equipment for enhanced diagnostic precision.

  • Expanding applications in regenerative medicine and biomarker research.

Challenges

  • High cost of advanced biopsy instruments and imaging systems.

  • Risk of complications and false-negative results in some biopsy procedures.

  • Lack of skilled professionals in developing regions for image-guided biopsy execution.

Despite these challenges, growing investments in healthcare infrastructure and continuous innovation are expected to sustain market expansion.

Key Players in the Global Biopsy Devices Market

The global biopsy devices market is moderately consolidated, with leading companies focusing on innovation, partnerships, and acquisitions to enhance their portfolios.

Major players include:

  • Becton, Dickinson and Company

  • Cook Group Incorporated

  • Devicor Medical Products, Inc.

  • Hologic Inc.

  • Argon Medical Devices, Inc.

  • B. Braun Medical Inc.

  • Cardinal Health, Inc.

  • Olympus Corporation

  • Boston Scientific Corporation

  • Medtronic plc

  • FUJIFILM Holdings Corporation

These companies are investing in R&D to develop advanced, less invasive, and high-precision biopsy solutions to meet the growing demand for early and accurate cancer diagnosis.

Future Outlook

The future of the biopsy devices market looks promising, with rising adoption of liquid biopsy and AI-integrated diagnostics. As healthcare systems worldwide focus on early detection, personalized treatment, and minimally invasive procedures, biopsy technologies will continue to evolve and expand across applications.

The market’s robust CAGR of 7.6% from 2025 to 2034 underscores its potential for sustained growth, particularly in regions like Asia Pacific and North America.

FAQs

1. What is the biopsy devices market?
The biopsy devices market refers to the global industry that manufactures and distributes medical tools used to collect tissue or fluid samples for diagnostic purposes, particularly in cancer detection and research.

2. How big is the global biopsy devices market?
The global biopsy devices market was valued at USD 7.27 billion in 2024 and is expected to reach USD 15.12 billion by 2034, growing at a CAGR of 7.6% during the forecast period.

3. What are the major factors driving the biopsy devices market?
Key growth factors include rising cancer prevalence, technological advancements in imaging-guided biopsy, increasing use of liquid biopsy, and expanding healthcare infrastructure.

4. Which region dominates the biopsy devices market?
North America holds the largest share due to advanced healthcare facilities, early adoption of technologies, and strong presence of key industry players.

5. Who are the leading players in the global biopsy devices market?
Top companies include Becton, Dickinson and Company, Hologic Inc., Boston Scientific Corporation, Medtronic plc, and FUJIFILM Holdings Corporation.